Due Before, During, and After Pregnancy

Co-Moderator(s)

• 

  Ursula Kirchmayer, MPH, FISPE

  MPH, FISPE
  Department of Epidemiology, Lazio Regional Health Service, Rome
  Roma, Italy
• CD

  Cécile Droz-Perroteau

  Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, 33000 Bordeaux, France
  Bordeaux, France

Presentations:

• 1:30 PM – 1:45 PM ADT

  Drug utilisation of valproate-containing medicinal products in women of childbearing potential in 5 European countries: a population-based network cohort study part of DARWIN EU®
  

  Presenting Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
• 1:45 PM – 2:00 PM ADT

  Determinants of non-compliance with the pregnancy prevention program in women initiating oral isotretinoin therapy: a cohort study from the French nationwide claims database
  

  Presenting Author: Anaïs Havet, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
• 2:00 PM – 2:15 PM ADT

  Use of Oral Preventive and Emergency Hormonal Contraceptives: Recent Trends and Response to the U.S. Supreme Court's Dobbs Decision
  

  Presenting Author: Dima M. Qato, PharmD, MPH, PhD – University of Southern California
• 2:15 PM – 2:30 PM ADT

  New Long-Acting Reversible Contraceptive Insertions More Than Doubled Among a Commercially Insured, U.S.-Based Outpatient Population from 2010 to 2020
  

  Presenting Author: Chase D. Latour – UNC Gillings School of Global Public Health
• 2:30 PM – 2:45 PM ADT

  Antithyroid Drug Use Before and During Pregnancy: Assessment of Switching Patterns and Changes Over Time
  

  Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
• 2:45 PM – 3:00 PM ADT

  Lithium in Pregnancy: A Utilization Study in the Five Nordic Countries
  

  Presenting Author: Felix Wittström, MD – Centre for Pharmacoepidemiology, Karolinska Institutet